Lorenzo Calvetti

1.4k total citations
23 papers, 566 citations indexed

About

Lorenzo Calvetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lorenzo Calvetti has authored 23 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Lorenzo Calvetti's work include Lung Cancer Treatments and Mutations (9 papers), Gastric Cancer Management and Outcomes (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Lorenzo Calvetti is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Gastric Cancer Management and Outcomes (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Lorenzo Calvetti collaborates with scholars based in Italy, China and United States. Lorenzo Calvetti's co-authors include Giuseppe Aprile, Giulia Pasello, Pierfranco Conté, Valentina Guarneri, Laura Bonanno, Alberto Pavan, Alessandro Dal Maso, Paola Ermacora, Stephen T. Sonis and Giuseppe Parisi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Lorenzo Calvetti

20 papers receiving 563 citations

Peers

Lorenzo Calvetti

ONCOL

PRM

OTORH

Ken Saijo Japan

Qingtao Zhao China

Shang‐Yin Wu Taiwan

Kensaku Ito Japan

Kwan Chee Allen Chan Hong Kong

Tatsunori Kiriu Japan

F. Rolland France

Hsiang‐Fong Kao Taiwan

М. В. Копп Russia

Federica Corso Italy

Ken Saijo Japan

Lorenzo Calvetti

232 ×0.6

ONCOL

133 ×0.4

PRM

52 ×0.5

203 ×2.1

68 ×0.8

OTORH

Citations per year, relative to Lorenzo Calvetti Lorenzo Calvetti (= 1×) peers Ken Saijo

Countries citing papers authored by Lorenzo Calvetti

Since Specialization

Citations

This map shows the geographic impact of Lorenzo Calvetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Calvetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Calvetti more than expected).

Fields of papers citing papers by Lorenzo Calvetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Calvetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Calvetti. The network helps show where Lorenzo Calvetti may publish in the future.

Co-authorship network of co-authors of Lorenzo Calvetti

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Calvetti. A scholar is included among the top collaborators of Lorenzo Calvetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Calvetti. Lorenzo Calvetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Hao, Jiarong Zhang, Atsushi Osoegawa, et al.. (2024). Radical resection in a patient with stage IIIA non-small cell lung cancer with the EGFR exon 19 deletion mutation after neoadjuvant targeted therapy with osimertinib: a case report. Translational Lung Cancer Research. 13(6). 1396–1406.

Bonanno, Laura, Lorenzo Calvetti, Alessandro Dal Maso, et al.. (2024). Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis. Frontiers in Immunology. 15. 1353889–1353889. 3 indexed citations

Zhang, Hang, et al.. (2023). Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case report. Journal of Thoracic Disease. 15(7). 4016–4026. 4 indexed citations

Calvetti, Lorenzo, et al.. (2023). EP13.03-02 Improved Long-Term Survival and Less Chemotherapy in Extended-SCLC Patients: A Real-World Study in the Immunotherapy Era. Journal of Thoracic Oncology. 18(11). S690–S690.

Bonanno, Laura, Alessandro Dal Maso, Alberto Pavan, et al.. (2022). Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?. British Journal of Cancer. 127(3). 383–393. 54 indexed citations

Belluomini, Lorenzo, Lorenzo Calvetti, Alessandro Inno, et al.. (2022). SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs. Frontiers in Oncology. 12. 840783–840783. 24 indexed citations

Pavan, Alberto, Lorenzo Calvetti, Alessandra Ferro, et al.. (2021). Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome. Translational Lung Cancer Research. 10(1). 202–220. 37 indexed citations

Basile, Debora, Francesca Simionato, Lorenzo Calvetti, et al.. (2021). Comparing immunotherapies to other frequently used treatments of gastric cancer. Expert Review of Clinical Pharmacology. 14(10). 1221–1232. 2 indexed citations

Simionato, Francesca, et al.. (2020). <p>Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring <em>EGFR</em> G719A/V769M Complex Mutation</p>. OncoTargets and Therapy. Volume 13. 12027–12031. 1 indexed citations

10.

Bersanelli, Melissa, Diana Giannarelli, Elena Verzoni, et al.. (2020). LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study. Annals of Oncology. 31. S1209–S1209. 4 indexed citations

11.

Calvetti, Lorenzo, et al.. (2020). Home-based management of cancer patients (CPs) experiencing toxicities while on anticancer treatment: The impact of a nurse-led telephone triage (NTT).. Journal of Clinical Oncology. 38(15_suppl). 2002–2002. 1 indexed citations

12.

Pavan, Alberto, Elisabetta Zulato, Lorenzo Calvetti, et al.. (2020). Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.. Journal of Clinical Oncology. 38(15_suppl). 3046–3046. 1 indexed citations

13.

Bonanno, Laura, Alberto Pavan, Alessandra Ferro, et al.. (2020). Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience. The Oncologist. 25(12). e1996–e2005. 23 indexed citations

14.

Fornaro, Lorenzo, Caterina Vivaldi, Clara Ugolini, et al.. (2019). Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer. British Journal of Cancer. 120(5). 522–526. 10 indexed citations

15.

Pavan, Alberto, Lorenzo Calvetti, Alessandro Dal Maso, et al.. (2019). Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel). Annals of Oncology. 30. v45–v45. 1 indexed citations

16.

Cinausero, M., Giuseppe Aprile, Paola Ermacora, et al.. (2017). New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Frontiers in Pharmacology. 8. 354–354. 189 indexed citations

17.

Calvetti, Lorenzo, Michele Pavarana, A. Auriemma, et al.. (2015). Effectiveness of Cetuximab (Cet) and Bevacizumab (Bev) for metastatic colorectal cancer (mCRC) according to primary tumor location (PTL): findings from a ‘real-world’ retrospective analysis. Annals of Oncology. 26. vi40–vi40. 3 indexed citations

18.

Calvetti, Lorenzo, Sara Pilotto, Luisa Carbognin, et al.. (2015). The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives. Expert Opinion on Biological Therapy. 15(9). 1359–1370. 12 indexed citations

19.

Melisi, Davide, Lorenzo Calvetti, Melissa Frizziero, & Giampaolo Tortora. (2014). Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease. Current Pharmaceutical Design. 20(42). 6660–6669. 30 indexed citations

20.

Lonardi, Sara, Lorenzo Fornaro, Francesca Bergamo, et al.. (2012). Phase II study of panitumumab (P) in combination with FOLFOXIRI as first-line treatment of metastatic colorectal cancer (mCRC): Activity in molecularly selected patients (pts).. Journal of Clinical Oncology. 30(15_suppl). 3555–3555. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact